Brain Organoids Reveal Glioblastoma Origins
UCSF postdoctoral researcher for the first time succeeded in keeping a diverse array of glioblastomas alive in the lab using brain organoids
University of California San Francisco
Give to UCSFUCSF postdoctoral researcher for the first time succeeded in keeping a diverse array of glioblastomas alive in the lab using brain organoids
Basic scientist Zena Werb, who has studied cancer cells in UCSF labs for more than four decades, shares her take on the future of cancer medicine.
A future in which precision medicine benefits everyone is not guaranteed. For that to happen, UCSF experts argue, the health care industry must first tackle today’s health disparities, including differences in disease outcomes and access to care based on race, gender, and socioeconomic status.
No one can see the future, but that won’t stop us from trying. We asked UCSF faculty and alumni to score these predictions for likelihood and impact.
From international awards for high-caliber research to groundswell movements for social change, this past year was an eventful one for the UCSF community.
Browse the stories that most engaged our readers in 2019.
Children and young adults with pediatric cancer are less likely to be alive five and 10 years following diagnosis if their health insurance is public, compared to those with private insurance.
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.
Now in its sixth year, the Best Global Universities rankings focus on schools’ academic research and reputation.
Ten finalists competed in the live event, hoping to impress the judges with snappy three-minute summaries of their research.
The UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff, will bring together scientists and physicians who seek to push the boundaries of prostate cancer research and devise new strategies to combat the disease.
A new genetic test found that Quincy's aggressive blood cancer had an unusual mutation on the FLT3 gene. That gave Quincy’s doctors a life-saving idea.
UCSF Benioff Children’s Hospitals have successfully treated a months-old infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer.
Patients increasingly resort to crowdfunding websites to pay medical bills, a new UCSF study finds that online donations are sought for lost wages, child care and even occasionally experimental treatments.
Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase.
A new web tool spells out for the first time the exposures that more than 6.5 million working women in California face that could increase their risk for breast cancer, including industrial solvents, antimicrobials and phthalates.
We talked with Lydia Zablotska, MD, PhD, about the real-life health impacts from the disaster portrayed in the HBO miniseries.
This documentary, about “a renegade scientist’s visionary quest to find a cure for cancer,” features immunologist James Allison, PhD, a residency alumnus and a former member of the UCSF and UC Berkeley faculties. Allison overcame many obstacles en route to his discovery of the immune system’s role in defeating cancer – work that won him a 2018 Nobel Prize. Narrated by Woody Harrelson, the film includes interviews with several current UCSF researchers, including Max Krummel, PhD, who as a graduate student in Allison’s UC Berkeley lab led several of the key studies recognized by the Nobel.
Using advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.
Today, our understanding of glioma subtypes has expanded to include the molecular and genetic variants that can influence a tumor’s development, prognosis, and response to treatment.
UCSF is opening a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.